HOOKIPA Pharma Inc (HOOK)
0.7615
+0.04
(+6.07%)
USD |
NASDAQ |
Apr 23, 16:00
0.78
+0.02
(+2.43%)
After-Hours: 16:27
HOOKIPA Pharma Cash from Financing (TTM): 65.67M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 65.67M |
September 30, 2023 | 44.22M |
June 30, 2023 | 45.01M |
March 31, 2023 | -3.757M |
December 31, 2022 | 72.27M |
September 30, 2022 | 72.06M |
June 30, 2022 | 71.92M |
March 31, 2022 | 74.96M |
December 31, 2021 | -0.235M |
September 30, 2021 | 75.25M |
June 30, 2021 | 75.04M |
Date | Value |
---|---|
March 31, 2021 | 74.80M |
December 31, 2020 | 73.42M |
September 30, 2020 | -2.539M |
June 30, 2020 | -2.849M |
March 31, 2020 | 73.31M |
December 31, 2019 | 109.75M |
September 30, 2019 | 110.64M |
June 30, 2019 | 111.17M |
March 31, 2019 | 35.15M |
December 31, 2018 | 6.873M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-3.757M
Minimum
Mar 2023
111.17M
Maximum
Jun 2019
60.01M
Average
72.27M
Median
Dec 2022
Cash from Financing (TTM) Benchmarks
Gilead Sciences Inc | -5.125B |
Absci Corp | -4.483M |
NovaBay Pharmaceuticals Inc | 1.91M |
Palatin Technologies Inc | 5.553M |
iBio Inc | 10.68M |